Tribunnews Reporter, Fitri Wulandari
TRIBUNNEWS.COM, NEW YORK – Pharmaceutical company United States of America (AS) Pfizer plans to seek U.S. Food and Drug Administration (FDA) clearance for use of booster doses of vaccine corona virus (Covid-19).
They claimed last Thursday that the third dose given within 12 months could ‘dramatically’ boost immunity and might help ward off new variants. Covid-19 which is worrying.
Quoted from the page NBC News, Sunday (11/7/2021), research from various countries shows a vaccine Pfizer and vaccines Covid-19 another widely used population in the world offers strong protection against variant B.1.617.2 (Delta).
Please note, the Delta variant is claimed to be highly contagious and can spread rapidly throughout the world.
Delta is currently cited as the cause of the emergence of new cases of infection in the majority of US citizens.
Two doses of most vaccines are not only considered essential for developing high levels of virus-fighting antibodies against the Delta variant, but also all variants. Covid-19.
But sadly, until now there are still many countries in the world that have not received the initial dose of protection, due to the limited vaccine and the many new variants that have emerged.
Also read: Covid in Germany: Between Demands for Normality and Fears of a New Wave of Delta Variants
While antibodies in the body, naturally decrease over time.
In this regard, research is underway to find out ‘if and when a booster dose is needed’.
–
